Memorial Göztepe Hospital
Memorial Göztepe Hospital
Turquie, Istanbul
Bookimed ne rajoute pas de frais pour les traitements de Maladie de Raynaud. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Maladie de Raynaud et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Maladie de Raynaud.
Dr. Nermina Alagic is an attending cardiologist at Anadolu Medical Center in Istanbul, a Johns Hopkins Medicine affiliate. She graduated from Istanbul University–Cerrahpaşa. She completed her cardiology residency at Istanbul Mehmet Akif Ersoy Thoracic and Cardiovascular Surgery Hospital (2014–2018). She focuses on cardiac imaging. She has expertise in 2D/3D transthoracic and transesophageal echocardiography (TTE/TEE). She advanced this training through research at the UAB Echo Lab (2015) and hands-on 2D/3D TEE work in the TEE Lab (2018–2019).
Her research covers photomedicine and cardiology. Her papers appear in Journal of Biomedical Optics, PNAS, Photochemistry and Photobiology, Echocardiography, Minerva Cardioangiologica, and Archives of Medical Science (2013–2020). She completed a clinical and interventional cardiology observership at Royal North Shore Hospital in Sydney (2019). She also worked at the Harvard Medical School Wellman Center for Photomedicine (2012–2013). She is a full member of the Turkish Society of Cardiology and the European Society of Cardiology, and an EACVI silver member. Award: ASP Fredrick Urbach Memorial Student Travel Award (2013).
Professeur agrégé de cardiologie ayant reçu une formation spécialisée à l'hôpital Dr Siyami Ersek, l'un des principaux centres cardiovasculaires de Turquie.
Dr. Cenk İndelen is a cardiovascular surgery specialist. He has practiced since 2002. He has worked at Istanbul Florence Nightingale Hospital since 2025. He completed his residency in thoracic, cardiovascular, and vascular surgery at Kocaeli University (1996–2002). He became an associate professor in 2023.
His focus is patient blood management and cardiothoracic optimization. He has published on transfusion cost-effectiveness and PBM implementation (Cardiovasc J Afr, 2023). He has also reported on the economics of aortic valve replacement (Heart Surg Forum, 2023) and techniques in coronary, mitral, and aortic surgery. His work also appears in JAMA (2023), Crit Care Med (2025), and Transfusion (2025).
Accreditations and memberships: Orsi da Vinci robotic console training (Belgium, 2014). Koç University Animal Use Certificate (2017). Society for the Advancement of Patient Blood Management course (2020). Publons Peer Reviewer course (2020). Member of the Turkish Society of Cardiovascular Surgery, ISMICS, the ERAS Society, the Blood Transfusion Society, the Society for the Advancement of PBM, and ASCVTS.
Raynaud's disease treatment in Turkey involves multidisciplinary care provided by cardiovascular surgeons and rheumatologists. Clinics utilize medications like calcium channel blockers to relax blood vessels. For severe cases, specialists perform surgical sympathectomy or Botox injections to prevent painful vessel spasms and improve circulation.
Bookimed Expert Insight: Turkish hospitals like Memorial Göztepe integrate advanced diagnostics with 3 Tesla MRI and 512-slice CT to rule out secondary causes. This high-resolution imaging helps doctors differentiate between primary disease and underlying autoimmune conditions. Identifying the specific cause early ensures the most effective drug-based or surgical protocol is chosen.
Patient Consensus: Patients note that care typically starts with lifestyle adjustments and medications before moving to procedures. They emphasize the importance of checking for autoimmune markers to ensure the treatment targets the root cause.
Primary Raynaud's disease has no known permanent cure. Patients manage the condition through lifestyle changes and medications. In secondary cases, treating the underlying autoimmune disorder can significantly improve symptoms. Turkish vascular specialists offer advanced management options including calcium channel blockers and nerve procedures.
Bookimed Expert Insight: While a cure is elusive, the depth of expertise in Istanbul is notable. Professor Deniz Suha Kucukaksu at Başkent University Istanbul Hospital brings 35+ years of experience in complex vascular surgery. This high level of specialization ensures patients receive management plans that go beyond basic lifestyle advice, utilizing the same imaging technologies found at Johns Hopkins-affiliated centers.
Patient Consensus: Patients note that keeping warm and avoiding sudden temperature drops are the most effective daily strategies. Many emphasize that a proper specialist evaluation in Turkey helps differentiate between primary and secondary types.
Select qualified Turkish clinics by prioritizing JCI-accredited centers with multidisciplinary vascular teams. Look for professors in cardiology or cardiovascular surgery with 20+ years of experience. High-tier facilities like Memorial Göztepe Hospital use 3 Tesla MRI and digital PET/CT to evaluate vascular damage precisely.
Bookimed Expert Insight: Our data shows that top physicians like Dr. Akin Torun and Dr. Nermina Alagic often hold dual affiliations with academic institutions and elite hospitals. This indicates a higher standard of diagnostic rigor. Dr. Alagic’s affiliation with Johns Hopkins Medicine suggests adherence to international protocols for complex secondary Raynaud’s cases.
Patient Consensus: Patients emphasize finding a doctor who treats Raynaud’s as a chronic circulation issue. They suggest avoiding any clinic that promises a permanent cure without first performing a full autoimmune screening.